BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31519379)

  • 1. The pituitary in nuclear medicine imaging.
    Iglesias P; Cardona J; Díez JJ
    Eur J Intern Med; 2019 Oct; 68():6-12. PubMed ID: 31519379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
    Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
    J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
    Zhao X; Xiao J; Xing B; Wang R; Zhu Z; Li F
    Clin Nucl Med; 2014 Jul; 39(7):605-8. PubMed ID: 24873787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.
    Seok H; Lee EY; Choe EY; Yang WI; Kim JY; Shin DY; Cho HJ; Kim TS; Yun MJ; Lee JD; Lee EJ; Lim SK; Rhee Y
    Korean J Intern Med; 2013 Jan; 28(1):81-8. PubMed ID: 23346000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of combination [
    Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H
    BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
    Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H
    Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
    Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
    J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenomas can appear as hypermetabolic lesions in (18) F-FDG PET imaging.
    Ryu SI; Tafti BA; Skirboll SL
    J Neuroimaging; 2010 Oct; 20(4):393-6. PubMed ID: 19453834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of 99mTc-HYNIC-TOC, 99mTc(V)-DMSA, and 99mTc-MIBI SPECT in the evaluation of pituitary adenomas.
    Vukomanovic VR; Matovic M; Doknic M; Ignjatovic V; Simic Vukomanovic I; Djukic S; Peulic M; Djukic A
    Nucl Med Commun; 2019 Jan; 40(1):41-51. PubMed ID: 30334858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of
    Wang Z; Mao Z; Zhang X; He D; Wang X; Du Q; Xiao Z; Zhu D; Zhu Y; Wang H
    Acad Radiol; 2019 Sep; 26(9):1222-1228. PubMed ID: 30318288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A; Ferone D; Lombardi G; Lastoria S
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.
    Jeong SY; Lee SW; Lee HJ; Kang S; Seo JH; Chun KA; Cho IH; Won KS; Zeon SK; Ahn BC; Lee J
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2334-43. PubMed ID: 20661556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by
    Ding L; Zhang F; He Q; Li Z; Shi X; Li R; Zhang X
    BMC Cancer; 2020 Jun; 20(1):564. PubMed ID: 32552842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
    de Herder WW; Reijs AE; Kwekkeboom DJ; Hofland LJ; Nobels FR; Oei HY; Krenning EP; Lamberts SW
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):755-67. PubMed ID: 9039343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary incidentaloma found on O-(2-18F-fluoroethyl)-l-tyrosine PET.
    Currie GM; Trifunovic M; Kiat H; Saunders C; Chung D; Ong YY; Wilkinson M; Witte K; Magnussen J
    J Nucl Med Technol; 2014 Sep; 42(3):218-22. PubMed ID: 24948822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
    Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
    Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.